Glycocalyx Degradation and Endothelial Dysfunction in Vaso-Occlusion: A Review

Author:

Obeagu Emmanuel IfeanyiORCID

Abstract

The endothelial glycocalyx is a crucial component of vascular homeostasis, acting as a protective barrier and regulator of endothelial function. In sickle cell anemia (SCA), the degradation of the glycocalyx significantly contributes to endothelial dysfunction and the pathogenesis of vaso-occlusive crises (VOCs). This review examines the mechanisms of glycocalyx degradation, including the roles of shear stress, enzymatic activity, and oxidative stress. The breakdown of the glycocalyx leads to increased vascular permeability, enhanced cell adhesion, and impaired nitric oxide (NO) production, all of which exacerbate endothelial dysfunction and promote VOCs. Mechanistically, shear stress and mechanical forces from altered hemodynamics in SCA disrupt the glycocalyx. Enzymes like heparanase, hyaluronidase, and matrix metalloproteinases degrade glycocalyx components, while oxidative stress from chronic inflammation and hemolysis further accelerates this process. The resulting endothelial dysfunction manifests as increased permeability, promoting inflammation and cell adhesion, and reduced NO synthesis, leading to vasoconstriction and thrombosis. This pro-thrombotic environment facilitates the adhesion and aggregation of sickled red blood cells (RBCs) and other circulating cells, driving VOCs. Therapeutic strategies targeting glycocalyx preservation and restoration are critical for mitigating endothelial dysfunction in SCA. Approaches include the use of glycocalyx precursors, synthetic mimetics, antioxidant therapy, enzyme inhibitors, and nitric oxide donors. These therapies aim to restore the glycocalyx, reduce oxidative stress, and improve NO bioavailability, thereby reducing the incidence and severity of VOCs. Continued research into these therapeutic interventions is essential for optimizing treatment and improving clinical outcomes for patients with SCA. Keywords: Glycocalyx, Endothelial Dysfunction, Vaso-Occlusion, Sickle Cell Anemia, Inflammation, Shear Stress, Endothelial Cells

Publisher

Society of Pharmaceutical Tecnocrats

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3